Kenvue Aktie News

Kenvue owns Johnson & Johnson's former over-the-counter brands. Medtronic has a diversified medical-device portfolio and is closing in on "Dividend King" status.

Five small IPOs debuted and four SPACs listed this week as the government shutdown continues to complicate listings. Two sizable IPOs are scheduled for the week ahead, both of which launched after the government shutdown began. Street research is expected for six companies in the week ahead, and two lock-up periods will be expiring.

Kenvue has urged U.S. regulators to reject a request for a warning of autism on its popular over-the-counter pain medication Tylenol for use during pregnancy, according to a petition.

Kenvue (KVUE 8.43%) isn't a household name. The consumer health products company has been around in its current form for only a couple of years.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

This article highlights top ReFa/Ro dividend stocks for September 2025, focusing on high yield and analyst-projected returns through September 2026. MFA Financial, Hafnia, and Energy Transfer lead the list, with projected net gains ranging from 30.84% to 70.61%. All top-ten ReFa/Ro "dogs" meet the ideal criterion: dividends from $1,000 invested exceed their share price, appealing to income-focu...

Major U.S. equities indexes climbed at midday Friday as regional bank stocks rebounded from yesterday's losses after a flurry of corporate earnings reports. The Dow, S&P 500, and Nasdaq were all higher.